BMO Capital Markets set a $85.00 price objective on Addus Homecare (NASDAQ:ADUS) in a report issued on Wednesday morning, TipRanks reports. The firm currently has a hold rating on the stock.
Several other equities analysts also recently commented on ADUS. Oppenheimer boosted their price target on shares of Addus Homecare from $80.00 to $91.00 and gave the stock a buy rating in a research note on Wednesday. Zacks Investment Research upgraded shares of Addus Homecare from a hold rating to a strong-buy rating and set a $79.00 price target for the company in a research note on Monday, May 13th. Sidoti boosted their price target on shares of Addus Homecare from $84.00 to $96.00 and gave the stock a buy rating in a research note on Tuesday, August 6th. BidaskClub upgraded shares of Addus Homecare from a hold rating to a buy rating in a research note on Saturday, July 27th. Finally, Raymond James set a $92.00 price target on shares of Addus Homecare and gave the stock an outperform rating in a research note on Wednesday. One analyst has rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of Buy and a consensus target price of $83.44.
NASDAQ:ADUS opened at $83.26 on Wednesday. The stock has a fifty day simple moving average of $77.65. The firm has a market capitalization of $1.07 billion, a P/E ratio of 45.26, a price-to-earnings-growth ratio of 2.49 and a beta of -0.10. The company has a current ratio of 2.84, a quick ratio of 2.87 and a debt-to-equity ratio of 0.17. Addus Homecare has a 52 week low of $56.75 and a 52 week high of $84.99.
In related news, CFO Brian Poff sold 20,000 shares of the business’s stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $70.57, for a total transaction of $1,411,400.00. Following the completion of the transaction, the chief financial officer now owns 38,241 shares in the company, valued at $2,698,667.37. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Mark L. First sold 440,000 shares of the business’s stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $74.08, for a total transaction of $32,595,200.00. Following the transaction, the director now owns 19,151 shares of the company’s stock, valued at approximately $1,418,706.08. The disclosure for this sale can be found here. Insiders own 20.10% of the company’s stock.
Hedge funds have recently modified their holdings of the stock. Marshall Wace North America L.P. acquired a new position in Addus Homecare in the first quarter valued at $34,000. Bank of Montreal Can boosted its stake in Addus Homecare by 58.9% in the first quarter. Bank of Montreal Can now owns 545 shares of the company’s stock valued at $35,000 after acquiring an additional 202 shares in the last quarter. C M Bidwell & Associates Ltd. acquired a new position in Addus Homecare in the second quarter valued at $40,000. South Dakota Investment Council acquired a new position in Addus Homecare in the first quarter valued at $83,000. Finally, Exane Derivatives acquired a new position in Addus Homecare in the second quarter valued at $95,000. Hedge funds and other institutional investors own 98.75% of the company’s stock.
Addus Homecare Company Profile
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
Read More: Why is Cost of Capital Important?
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.